Literature DB >> 36175666

[Chordoma-An update].

K Mellert1, C Seeling1,2, P Möller1, T F E Barth3.   

Abstract

Chordomas are rare malignant tumors of the axial skeleton with notochordal differentiation. From a morphological point of view, chordomas display a broad spectrum ranging from the classical, conventional form not otherwise specified (NOS) to forms with hepatoid or renal carcinoma-like differentiation or even poorly or dedifferentiated variants. The detection of brachyury is highly characteristic, though not exclusive. The morphological differential diagnosis from a benign notochordal tumor (BNCT) requires integration of imaging since BNCT is limited to the vertebral bodies and is not osteolytic. Targeted therapy is a current research focus and cell lines as in vitro models are a precondition for the establishment and validation of this approach.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Cell lines; Chordomas; Immunohistology; Morphology; Targeted therapy

Year:  2022        PMID: 36175666     DOI: 10.1007/s00292-022-01118-9

Source DB:  PubMed          Journal:  Pathologie (Heidelb)        ISSN: 2731-7188


  4 in total

1.  Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma.

Authors:  Holger Hof; Thomas Welzel; Jürgen Debus
Journal:  Onkologie       Date:  2006-12-11

2.  U-CH17P, -M and -S, a new cell culture system for tumor diversity and progression in chordoma.

Authors:  D Jäger; A Lechel; U Tharehalli; C Seeling; P Möller; T F E Barth; K Mellert
Journal:  Int J Cancer       Date:  2017-11-27       Impact factor: 7.396

3.  Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish.

Authors:  Gianluca D'Agati; Elena María Cabello; Karl Frontzek; Elisabeth J Rushing; Robin Klemm; Mark D Robinson; Richard M White; Christian Mosimann; Alexa Burger
Journal:  Dis Model Mech       Date:  2019-07-16       Impact factor: 5.758

4.  HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.

Authors:  Daniela Jäger; Thomas F E Barth; Silke Brüderlein; Angelika Scheuerle; Beate Rinner; Adrian von Witzleben; André Lechel; Patrick Meyer; Regine Mayer-Steinacker; Alexandra von Baer; Markus Schultheiss; Christian R Wirtz; Peter Möller; Kevin Mellert
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.